| - GRCh37:
- Chr15:34537898
- GRCh38:
- Chr15:34245697
| SLC12A6 | L548fs, L556fs, L592fs, L598fs, L607fs | Agenesis of the corpus callosum with peripheral neuropathy | Likely pathogenic
(Apr 4, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr15:34546683
- GRCh38:
- Chr15:34254482
| SLC12A6 | M270fs, M278fs, M314fs, M320fs, M329fs | Agenesis of the corpus callosum with peripheral neuropathy | Likely pathogenic
(Jan 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:34544412-34544413
- GRCh38:
- Chr15:34252211-34252212
| SLC12A6 | S372fs, S380fs, S416fs, S422fs, S431fs | Agenesis of the corpus callosum with peripheral neuropathy | Likely pathogenic
(Jan 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:34536244-34536245
- GRCh38:
- Chr15:34244043-34244044
| SLC12A6 | N599fs, N607fs, N643fs, N649fs, N658fs | Agenesis of the corpus callosum with peripheral neuropathy | Likely pathogenic
(Jan 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:34533435-34533436
- GRCh38:
- Chr15:34241234-34241235
| SLC12A6 | W696fs, W704fs, W740fs, W746fs, W755fs | Agenesis of the corpus callosum with peripheral neuropathy | Likely pathogenic
(Dec 31, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr15:34543119-34543121
- GRCh38:
- Chr15:34250918-34250920
| SLC12A6 | I432fs, I440fs, I476fs, I482fs, I491fs | Agenesis of the corpus callosum with peripheral neuropathy | Likely pathogenic
(Dec 30, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr15:34546682-34546686
- GRCh38:
- Chr15:34254481-34254485
| SLC12A6 | L269fs, L277fs, L313fs, L319fs, L328fs | Agenesis of the corpus callosum with peripheral neuropathy | Likely pathogenic
(Dec 30, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr15:34549973-34549974
- GRCh38:
- Chr15:34257772-34257773
| SLC12A6 | T128fs, T136fs, T172fs, T178fs, T187fs | Agenesis of the corpus callosum with peripheral neuropathy | Likely pathogenic
(Dec 17, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr15:34529622-34529625
- GRCh38:
- Chr15:34237421-34237424
| SLC12A6 | E918fs, E926fs, E962fs, E968fs, E977fs | Agenesis of the corpus callosum with peripheral neuropathy | Likely pathogenic
(Dec 16, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr15:34551031
- GRCh38:
- Chr15:34258830
| SLC12A6 | K117*, K125*, K161*, K167*, K176* | Agenesis of the corpus callosum with peripheral neuropathy | Likely pathogenic
(May 28, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:34533013
- GRCh38:
- Chr15:34240812
| SLC12A6 | L703*, L711*, L747*, L753*, L762* | Agenesis of the corpus callosum with peripheral neuropathy | Likely pathogenic
(May 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:34538006-34538007
- GRCh38:
- Chr15:34245805-34245806
| SLC12A6 | V512fs, V520fs, V556fs, V562fs, V571fs | Agenesis of the corpus callosum with peripheral neuropathy | Likely pathogenic
(May 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:34534365
- GRCh38:
- Chr15:34242164
| SLC12A6 | W641fs, W649fs, W685fs, W691fs, W700fs | Agenesis of the corpus callosum with peripheral neuropathy | Likely pathogenic
(Apr 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:34533435-34533441
- GRCh38:
- Chr15:34241234-34241240
| SLC12A6 | N695fs, N703fs, N739fs, N745fs, N754fs | Agenesis of the corpus callosum with peripheral neuropathy | Likely pathogenic
(Mar 31, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:34531346
- GRCh38:
- Chr15:34239145
| LOC126862097, SLC12A6 | M759fs, M767fs, M803fs, M809fs, M818fs | Agenesis of the corpus callosum with peripheral neuropathy | Likely pathogenic
(Mar 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:34549976
- GRCh38:
- Chr15:34257775
| SLC12A6 | G127fs, G135fs, G171fs, G177fs, G186fs | Agenesis of the corpus callosum with peripheral neuropathy | Likely pathogenic
(Mar 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:34530535
- GRCh38:
- Chr15:34238334
| SLC12A6 | S842fs, S850fs, S886fs, S892fs, S901fs | Agenesis of the corpus callosum with peripheral neuropathy | Likely pathogenic
(Mar 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:34528320
- GRCh38:
- Chr15:34236119
| SLC12A6 | Y1026*, Y1032*, Y1041*, Y982*, Y990* | Agenesis of the corpus callosum with peripheral neuropathy | Likely pathogenic
(Mar 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:34544484-34544485
- GRCh38:
- Chr15:34252283-34252284
| SLC12A6 | G348fs, G356fs, G392fs, G398fs, G407fs | Agenesis of the corpus callosum with peripheral neuropathy | Likely pathogenic
(Mar 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:34536220
- GRCh38:
- Chr15:34244019
| SLC12A6 | L607*, L615*, L651*, L657*, L666* | Agenesis of the corpus callosum with peripheral neuropathy | Likely pathogenic
(Mar 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:34542904
- GRCh38:
- Chr15:34250703
| SLC12A6 | G448*, G456*, G492*, G498*, G507* | Agenesis of the corpus callosum with peripheral neuropathy | Likely pathogenic
(Mar 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:34528921-34528922
- GRCh38:
- Chr15:34236720-34236721
| SLC12A6 | E1001fs, E1010fs, E951fs, E959fs, E995fs | Agenesis of the corpus callosum with peripheral neuropathy | Likely pathogenic
(Mar 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:34551037-34551038
- GRCh38:
- Chr15:34258836-34258837
| SLC12A6 | E115fs, E123fs, E159fs, E165fs, E174fs | Agenesis of the corpus callosum with peripheral neuropathy | Likely pathogenic
(Feb 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:34544386
- GRCh38:
- Chr15:34252185
| SLC12A6 | S381fs, S389fs, S425fs, S431fs, S440fs | Agenesis of the corpus callosum with peripheral neuropathy | Likely pathogenic
(Feb 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:34553146-34553150
- GRCh38:
- Chr15:34260945-34260949
| SLC12A6 | D115fs, D121fs, D130fs, D71fs, D79fs | Agenesis of the corpus callosum with peripheral neuropathy | Likely pathogenic
(Feb 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:34528938-34528939
- GRCh38:
- Chr15:34236737-34236738
| SLC12A6 | R1005fs, R946fs, R954fs, R990fs, R996fs | Agenesis of the corpus callosum with peripheral neuropathy | Likely pathogenic
(Feb 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:34546675
- GRCh38:
- Chr15:34254474
| SLC12A6 | L272*, L280*, L316*, L322*, L331* | Agenesis of the corpus callosum with peripheral neuropathy | Likely pathogenic
(Feb 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:34553208-34553209
- GRCh38:
- Chr15:34261007-34261008
| SLC12A6 | K101fs, K110fs, K51fs, K59fs, K95fs | Agenesis of the corpus callosum with peripheral neuropathy | Likely pathogenic
(Feb 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:34532867-34532868
- GRCh38:
- Chr15:34240666-34240667
| SLC12A6 | E752fs, E760fs, E796fs, E802fs, E811fs | Agenesis of the corpus callosum with peripheral neuropathy | Likely pathogenic
(Feb 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:34544553
- GRCh38:
- Chr15:34252352
| SLC12A6 | S325*, S333*, S369*, S375*, S384* | Agenesis of the corpus callosum with peripheral neuropathy | Likely pathogenic
(Jan 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:34537895-34537896
- GRCh38:
- Chr15:34245694-34245695
| SLC12A6 | R549fs, R557fs, R593fs, R599fs, R608fs | Agenesis of the corpus callosum with peripheral neuropathy | Likely pathogenic
(Jan 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:34549983-34549984
- GRCh38:
- Chr15:34257782-34257783
| SLC12A6 | Q125fs, Q133fs, Q169fs, Q175fs, Q184fs | Agenesis of the corpus callosum with peripheral neuropathy | Likely pathogenic
(Jan 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:34536266-34536267
- GRCh38:
- Chr15:34244065-34244066
| SLC12A6 | L592fs, L600fs, L636fs, L642fs, L651fs | Agenesis of the corpus callosum with peripheral neuropathy | Likely pathogenic
(Aug 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:34528367
- GRCh38:
- Chr15:34236166
| SLC12A6 | R1011*, R1017*, R1026*, R967*, R975* | Agenesis of the corpus callosum with peripheral neuropathy | Likely pathogenic
(Dec 10, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr15:34537620
- GRCh38:
- Chr15:34245419
| SLC12A6 | | Agenesis of the corpus callosum with peripheral neuropathy, not provided | Likely benign
(Oct 26, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:34528987-34528988
- GRCh38:
- Chr15:34236786-34236787
| SLC12A6 | E938fs, E989fs, E980fs, E930fs, E974fs | not provided, Agenesis of the corpus callosum with peripheral neuropathy | Pathogenic/Likely pathogenic
(Jan 25, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:34532975
- GRCh38:
- Chr15:34240774
| SLC12A6 | R716C, R724C, R760C, R766C, R775C | Inborn genetic diseases, Agenesis of the corpus callosum with peripheral neuropathy, not provided
| Uncertain significance
(Dec 19, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:34610837
- GRCh38:
- Chr15:34318636
| SLC12A6 | G15R | Agenesis of the corpus callosum with peripheral neuropathy | Uncertain significance
(Jun 5, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr15:34567540
- GRCh38:
- Chr15:34275339
| SLC12A6 | | not provided, Agenesis of the corpus callosum with peripheral neuropathy | Conflicting interpretations of pathogenicity
(Mar 4, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr15:34542829
- GRCh38:
- Chr15:34250628
| SLC12A6 | | Agenesis of the corpus callosum with peripheral neuropathy | Likely pathogenic
(Dec 5, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr15:34546558
- GRCh38:
- Chr15:34254357
| SLC12A6 | P311L, P319L, P355L, P361L, P370L | not provided | Uncertain significance
(Dec 18, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr15:34610964
- GRCh38:
- Chr15:34318763
| SLC12A6 | | not provided, Agenesis of the corpus callosum with peripheral neuropathy | Benign
(Jul 10, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:34528475
- GRCh38:
- Chr15:34236274
| SLC12A6 | | not provided, Agenesis of the corpus callosum with peripheral neuropathy | Benign
(Jul 10, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:34553226
- GRCh38:
- Chr15:34261025
| SLC12A6 | | not provided | Benign
(Oct 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:34538059
- GRCh38:
- Chr15:34245858
| SLC12A6 | | not provided | Likely benign
(Jun 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:34537903
- GRCh38:
- Chr15:34245702
| SLC12A6 | | Agenesis of the corpus callosum with peripheral neuropathy, Inborn genetic diseases, not provided
| Likely benign
(Sep 16, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:34547563
- GRCh38:
- Chr15:34255362
| SLC12A6 | A200fs, A208fs, A244fs, A250fs, A259fs | not provided, Agenesis of the corpus callosum with peripheral neuropathy | Pathogenic/Likely pathogenic
(May 12, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:34531205
- GRCh38:
- Chr15:34239004
| LOC126862097, SLC12A6 | R806S, R856S, R865S, R814S, R850S | Agenesis of the corpus callosum with peripheral neuropathy | Uncertain significance
(Jul 31, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr15:34544553
- GRCh38:
- Chr15:34252352
| SLC12A6 | S333*, S369*, S325*, S375*, S384* | Agenesis of the corpus callosum with peripheral neuropathy | Pathogenic
(Jun 3, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr15:34533471
- GRCh38:
- Chr15:34241270
| SLC12A6 | R693*, R729*, R744*, R685*, R735* | not provided, Agenesis of the corpus callosum with peripheral neuropathy | Pathogenic
(Aug 7, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:34546782
- GRCh38:
- Chr15:34254581
| SLC12A6 | | Inborn genetic diseases, not provided | Likely benign
(Oct 31, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:34546714
- GRCh38:
- Chr15:34254513
| SLC12A6 | M259T, M267T, M303T, M309T, M318T | Agenesis of the corpus callosum with peripheral neuropathy | Uncertain significance
(Apr 18, 2020) | no assertion criteria provided |
| - GRCh37:
- Chr15:34546602
- GRCh38:
- Chr15:34254401
| SLC12A6 | I296M, I304M, I340M, I346M, I355M | Agenesis of the corpus callosum with peripheral neuropathy | Uncertain significance
(Apr 18, 2020) | no assertion criteria provided |
| - GRCh37:
- Chr15:34546588
- GRCh38:
- Chr15:34254387
| SLC12A6 | A301G, A309G, A345G, A351G, A360G | Agenesis of the corpus callosum with peripheral neuropathy | Uncertain significance
(Aug 13, 2020) | no assertion criteria provided |
| - GRCh37:
- Chr15:34544462
- GRCh38:
- Chr15:34252261
| SLC12A6 | | not provided | Likely benign
(Oct 20, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:34544444
- GRCh38:
- Chr15:34252243
| SLC12A6 | | not provided, Inborn genetic diseases | Likely benign
(Feb 24, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:34543223
- GRCh38:
- Chr15:34251022
| SLC12A6 | I398F, I406F, I442F, I448F, I457F | not provided | Uncertain significance
(Aug 28, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:34543108
- GRCh38:
- Chr15:34250907
| SLC12A6 | S436C, S444C, S480C, S486C, S495C | not provided | Uncertain significance
(Feb 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:34538075
- GRCh38:
- Chr15:34245874
| SLC12A6 | | not provided, Agenesis of the corpus callosum with peripheral neuropathy | Likely benign
(Aug 4, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:34537603
- GRCh38:
- Chr15:34245402
| SLC12A6 | V550A, V558A, V594A, V600A, V609A | Inborn genetic diseases, not provided, Agenesis of the corpus callosum with peripheral neuropathy
| Uncertain significance
(Jul 19, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:34537582
- GRCh38:
- Chr15:34245381
| SLC12A6 | N557S, N565S, N601S, N607S, N616S | not provided, Agenesis of the corpus callosum with peripheral neuropathy | Uncertain significance
(Aug 21, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:34536283
- GRCh38:
- Chr15:34244082
| SLC12A6 | | not provided | Likely benign
(Aug 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:34534356
- GRCh38:
- Chr15:34242155
| SLC12A6 | | not provided | Likely benign
(Nov 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:34530594
- GRCh38:
- Chr15:34238393
| SLC12A6 | | not provided | Likely benign
(Jul 30, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr15:34530539-34530541
- GRCh38:
- Chr15:34238338-34238340
| SLC12A6 | F840del, F848del, F884del, F890del, F899del | Agenesis of the corpus callosum with peripheral neuropathy | Uncertain significance
(Apr 18, 2020) | no assertion criteria provided |
| - GRCh37:
- Chr15:34529019-34529020
- GRCh38:
- Chr15:34236818-34236819
| SLC12A6 | | Agenesis of the corpus callosum with peripheral neuropathy | Uncertain significance
(Apr 18, 2020) | no assertion criteria provided |
| - GRCh37:
- Chr15:34528990
- GRCh38:
- Chr15:34236789
| SLC12A6 | | not provided | Likely benign
(Sep 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:34528350
- GRCh38:
- Chr15:34236149
| SLC12A6 | | Agenesis of the corpus callosum with peripheral neuropathy | Uncertain significance
(Apr 18, 2020) | no assertion criteria provided |
| - GRCh37:
- Chr15:34528341
- GRCh38:
- Chr15:34236140
| SLC12A6 | | Agenesis of the corpus callosum with peripheral neuropathy | Uncertain significance
(Apr 18, 2020) | no assertion criteria provided |
| - GRCh37:
- Chr15:34528323
- GRCh38:
- Chr15:34236122
| SLC12A6 | | not provided | Likely benign
(Aug 16, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:34528269
- GRCh38:
- Chr15:34236068
| SLC12A6 | | not provided | Likely benign
(Nov 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:34527473
- GRCh38:
- Chr15:34235272
| SLC12A6 | | Agenesis of the corpus callosum with peripheral neuropathy | Uncertain significance
(Apr 18, 2020) | no assertion criteria provided |
| - GRCh37:
- Chr15:34628890
- GRCh38:
- Chr15:34336689
| SLC12A6 | | Agenesis of the corpus callosum with peripheral neuropathy | Uncertain significance
(Apr 18, 2020) | no assertion criteria provided |
| - GRCh37:
- Chr15:34628857-34628859
- GRCh38:
- Chr15:34336656-34336658
| SLC12A6 | T8del | not provided | Uncertain significance
(Jun 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:34628827
- GRCh38:
- Chr15:34336626
| SLC12A6 | P10S, P19S | Agenesis of the corpus callosum with peripheral neuropathy | Uncertain significance
(Apr 18, 2020) | no assertion criteria provided |
| - GRCh37:
- Chr15:34628706
- GRCh38:
- Chr15:34336505
| SLC12A6 | P50R, P59R | not provided | Uncertain significance
(Mar 22, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:34628642
- GRCh38:
- Chr15:34336441
| SLC12A6 | | not provided | Likely benign
(Jul 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:34567568
- GRCh38:
- Chr15:34275367
| SLC12A6 | | not provided | Likely benign
(Aug 22, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr15:34551102
- GRCh38:
- Chr15:34258901
| SLC12A6 | R101H, R137H, R143H, R152H, R93H | not provided | Uncertain significance
(Aug 11, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:34551033
- GRCh38:
- Chr15:34258832
| SLC12A6 | G116E, G124E, G160E, G166E, G175E | Agenesis of the corpus callosum with peripheral neuropathy | Uncertain significance
(Apr 18, 2020) | no assertion criteria provided |
| - GRCh37:
- Chr15:34549875
- GRCh38:
- Chr15:34257674
| LOC129390683, SLC12A6 | A161S, A169S, A205S, A211S, A220S | Agenesis of the corpus callosum with peripheral neuropathy | Uncertain significance
(Apr 18, 2020) | no assertion criteria provided |
| - GRCh37:
- Chr15:34547487
- GRCh38:
- Chr15:34255286
| SLC12A6 | I225M, I233M, I269M, I275M, I284M | Agenesis of the corpus callosum with peripheral neuropathy | Uncertain significance
(Apr 18, 2020) | no assertion criteria provided |
| - GRCh37:
- Chr15:34547478
- GRCh38:
- Chr15:34255277
| SLC12A6 | | not provided | Likely benign
(Oct 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:34547477
- GRCh38:
- Chr15:34255276
| SLC12A6 | I229V, I237V, I273V, I279V, I288V | Agenesis of the corpus callosum with peripheral neuropathy | Uncertain significance
(Apr 18, 2020) | no assertion criteria provided |
| - GRCh37:
- Chr15:34567545
- GRCh38:
- Chr15:34275344
| SLC12A6 | | not provided, Agenesis of the corpus callosum with peripheral neuropathy | Likely pathogenic
(Oct 16, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:34544505
- GRCh38:
- Chr15:34252304
| SLC12A6 | T341I, T400I, T349I, T385I, T391I | Agenesis of the corpus callosum with peripheral neuropathy | Uncertain significance
(Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr15:34543091
- GRCh38:
- Chr15:34250890
| SLC12A6 | | Agenesis of the corpus callosum with peripheral neuropathy | Uncertain significance
(Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr15:34525911
- GRCh38:
- Chr15:34233710
| SLC12A6 | | Agenesis of the corpus callosum with peripheral neuropathy | Uncertain significance
(Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr15:34525879
- GRCh38:
- Chr15:34233678
| SLC12A6 | | Agenesis of the corpus callosum with peripheral neuropathy | Uncertain significance
(Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr15:34525805
- GRCh38:
- Chr15:34233604
| SLC12A6 | | Agenesis of the corpus callosum with peripheral neuropathy | Uncertain significance
(Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr15:34525626
- GRCh38:
- Chr15:34233425
| SLC12A6 | | Agenesis of the corpus callosum with peripheral neuropathy | Uncertain significance
(Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr15:34525621
- GRCh38:
- Chr15:34233420
| SLC12A6 | | Agenesis of the corpus callosum with peripheral neuropathy | Uncertain significance
(Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr15:34525608
- GRCh38:
- Chr15:34233407
| SLC12A6 | | Agenesis of the corpus callosum with peripheral neuropathy | Uncertain significance
(Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr15:34525456
- GRCh38:
- Chr15:34233255
| SLC12A6 | | Agenesis of the corpus callosum with peripheral neuropathy | Uncertain significance
(Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr15:34524833
- GRCh38:
- Chr15:34232632
| SLC12A6 | | Agenesis of the corpus callosum with peripheral neuropathy | Uncertain significance
(Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr15:34524475
- GRCh38:
- Chr15:34232274
| SLC12A6 | | Agenesis of the corpus callosum with peripheral neuropathy | Uncertain significance
(Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr15:34523422
- GRCh38:
- Chr15:34231221
| SLC12A6 | | Agenesis of the corpus callosum with peripheral neuropathy | Uncertain significance
(Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr15:34523328
- GRCh38:
- Chr15:34231127
| SLC12A6 | | Agenesis of the corpus callosum with peripheral neuropathy | Uncertain significance
(Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr15:34523253
- GRCh38:
- Chr15:34231052
| SLC12A6 | | Agenesis of the corpus callosum with peripheral neuropathy | Uncertain significance
(Jan 15, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr15:34523183
- GRCh38:
- Chr15:34230982
| SLC12A6 | | Agenesis of the corpus callosum with peripheral neuropathy | Uncertain significance
(Jan 13, 2018) | criteria provided, single submitter |